HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Subchronic studies in Sprague-Dawley rats to investigate mechanisms of MTBE-induced Leydig cell cancer.

Abstract
High MTBE exposures caused rat Leydig cell (LC) tumors in inhalation and gavage cancer bioassays. Investigating early endocrine changes consistent with known mechanisms of LC carcinogenesis, we gavaged adult male Sprague-Dawley rats with MTBE in five different subchronic experiments and studied testosterone biosynthesis in isolated rat LCs exposed in vitro to MTBE or a major metabolite, t-butanol. In vitro LC testosterone production declined 29-50% following 3-h exposures to 50-100 mM MTBE or t-butanol. Within hours after gavaging with 1,000 or 1,500 mg/kg MTBE, circulating testosterone declined to 38-49% of control (p < 0.05). If sampled longer after treatment or with lower doses, testosterone reductions were less dramatic or nondetectable even after 28 days of treatment. Accessory organ:brain weight ratios decreased only slightly although showing dose response with 40-800 mg/kg/day after 28 days. High MTBE doses caused slight liver weight and total P450 increases. Reduced aromatase activity in liver and testis microsomes predicted low serum estradiol, but estradiol was 19% higher than corn oil controls concurrent with testosterone reduction 1 h after the last of 14 daily 1,200-mg/kg doses (p < 0.05). Pituitary luteinizing hormone (LH) and prolactin measured in both intact and orchiectomized rats, with testosterone implants in some castrated rats providing stable levels of testosterone, revealed no consistent direct effect on hypothalamic-pituitary function. MTBE-treated rat livers showed no evidence of peroxisome proliferation, a characteristic of some LC carcinogens. Considering recognized mechanisms of Leydig cell cancer in rats, collectively these results suggested reduced LC steroidogenesis enzyme activity as a possible mechanism underlying MTBE LC carcinogenesis.
AuthorsAnn de Peyster, Kathryn J MacLean, Beth A Stephens, Lisa D Ahern, Christian M Westover, Diana Rozenshteyn
JournalToxicological sciences : an official journal of the Society of Toxicology (Toxicol Sci) Vol. 72 Issue 1 Pg. 31-42 (Mar 2003) ISSN: 1096-6080 [Print] United States
PMID12604832 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Carcinogens
  • Gonadotropins
  • Methyl Ethers
  • Pituitary Hormones
  • Solvents
  • methyl tert-butyl ether
  • Testosterone
  • Estradiol
  • Luteinizing Hormone
  • Cytochrome P-450 Enzyme System
  • Aromatase
  • Corticosterone
Topics
  • Administration, Inhalation
  • Animals
  • Aromatase (metabolism)
  • Carcinogens (adverse effects, toxicity)
  • Corticosterone (metabolism)
  • Cytochrome P-450 Enzyme System (metabolism)
  • Estradiol (metabolism)
  • Gonadotropins (metabolism)
  • Leydig Cell Tumor (chemically induced, metabolism, pathology)
  • Luteinizing Hormone (metabolism)
  • Male
  • Methyl Ethers (adverse effects, toxicity)
  • Orchiectomy
  • Organ Size (drug effects)
  • Peroxisomes (physiology)
  • Pituitary Hormones (metabolism)
  • Rats
  • Rats, Sprague-Dawley
  • Solvents (toxicity)
  • Testosterone (blood, metabolism)
  • Toxicity Tests, Chronic
  • Tumor Cells, Cultured
  • Weight Gain (drug effects)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: